Biogen Inc. buy Traumtanz
Start price
03.07.23
/
50%
€262.20
Target price
03.07.24
€270.00
Performance (%)
-25.51%
End price
27.04.24
-
Summary
This prediction is currently being closed. The prediction for Biogen Inc. disappoints with a performance of -25.51%. Traumtanz has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Traumtanz has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 7.014% | 7.014% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
According to Traumtanz what are the pros and cons of Biogen Inc. for the foreseeable future?
Pros
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Fair valuation
ROE higher than 10% per year
Good culture
Some uniques
Top 10 in its market
Small cyclical dependencies
Known brand
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High dividend yield expected
positive Cash Flow expected
Valuable balance sheet
Normal challenges to pay loans and raise capital
Capable Management
Cons
Comments by Traumtanz for this prediction
In the thread Biogen Inc. diskutieren
Buy mit Kursziel 270,0
In the thread Trading Biogen Inc.
Buy beendet
Current prediction by Traumtanz for Biogen Inc.
Biogen Inc.
Start price
Target price
Perf. (%)
€195.30
27.04.24
27.04.24
€200.00
-
26.04.24
26.04.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
